Flora briològica i pteridològica

Es comenten les característiques de les flores briltlògiques i pteridològiques de l'arxipèlag de Cabrera. Hom coneix actualment 24 espècies de briòfites ( 21 molses i 3 hepàtiques) i 8 espècies de falgueres, les quals presenten, en general, una ampla distribució a la resta de Balears. Els briòfits Rhynchostegiella tenella (Dicks.) Limpr. i Scorpiurium circinatum (Brid.) Fleish & Loeske són novetat per Cabrera.The known bryophyte flora of Cabrera island has 24 species (21 mosses and 3 liverworts), two of which Rhynchostegiella tenella (Dicks.) Limpr. and Scorpiurium circinatum (Brid.) Fleish & Loeske are new additions. On the other hand, only 8 pteridophyte species are recorded from Cabrera. Both, bryophyte and pteridophyte species, are well recorded from other Balearic islands

Preventive plan hamstring in football kid

El propósito de nuestro estudio es trabajar en un programa de prevención de lesiones en isquiotibiales en jóvenes futbolistas de la etapa infantil (13-14 años), realizando un pretest a todos los sujetos (4 grupos), aplicando un entrenamiento de ADM isquiotibial diferente, y volviendo a hacer un posterior postest transcurridas 10 semanas de entrenamientos, para comprobar qué grupo mejora más trasladando esas mejoras al entrenamiento específico. Para llevar a cabo nuestro estudio hemos requerido 44 jugadores de la categoría infantil. La muestra se clasificó por grupo trabajo por pareja (n1=13), trabajo en parejas + trabajo excéntrico (Hamstrings Nordics) (n2=10), trabajo SGA (n3=7) y trabajo SGA + trabajo excéntrico (Hamstrings Nordics) (n4=14), siendo cada grupo un equipo diferente. Los resultados obtenidos de este estudio son que con cualquier tipo de entrenamiento de ADM vamos a mejorar esta cualidad, sin grandes diferencias entre los diferentes grupos

Dynamic behaviour of bridges under critical conventional and regular trains: Review of some regulations included in EN 1991-2

[EN] In the field of structural analysis dedicated to the study of vibrations of high-speed railway bridges, one reference load model is the well-known HSLM-A, which limits of validity are stated in Eurocode EN 1991-2, Annex E. In a recent paper published in the Journal of Rail and Rapid Transit, the authors investigated the degree of coverage provided by HSLM-A to critical articulated trains. Now in the present article, the authors have extended those analyses to critical conventional and regular trains as well. This is an important aspect because HSLM-A as such is an articulated-type model, so it is of interest to understand how it deals with covering the various resonance phenomena generated by other train types. Therefore, the main goal of this work is to establish whether the conventional and regular trains that stem from the validity rules given in Annex E/EN 1991-2, produce vibratory effects that are duly covered by HSLM-A. Following the aforementioned validity rules, one first aspect analysed is the importance of near-to-integer wheelbase ratios in the coupled vibrations produced by conventional trains. Subsequently, seven realistic, conventional and regular high-speed train models have been synthesised; these models have been made publicly available in Mendeley Data, and comprise almost 3800 different sequences of axle loads. Finally, the response of simply-supported bridges has been analysed with a view to compare the seven synthesised models versus HSLM-A. The exceedance and required speed increase have been computed for both displacements and accelerations, in a comprehensive ensemble of spans and speeds. The results provide a diagnosis of the degree of coverage of HSLM-A with respect to those conventional and regular trains compliant with Annex E/EN 1991-2.This project has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 101012456.Museros Romero, P.; Andersson, A.; Pinazo, B. (2024). Dynamic behaviour of bridges under critical conventional and regular trains: Review of some regulations included in EN 1991-2. Proceedings of the Institution of Mechanical Engineers Part F Journal of Rail and Rapid Transit. 238(8):977-988. https://doi.org/10.1177/09544097241245150977988238

Global Metabolomic Profiling of Acute Myocarditis Caused by Trypanosoma cruzi Infection

© 2014 Gironès et al. Chagas disease is caused by Trypanosoma cruzi infection, being cardiomyopathy the more frequent manifestation. New chemotherapeutic drugs are needed but there are no good biomarkers for monitoring treatment efficacy. There is growing evidence linking immune response and metabolism in inflammatory processes and specifically in Chagas disease. Thus, some metabolites are able to enhance and/or inhibit the immune response. Metabolite levels found in the host during an ongoing infection could provide valuable information on the pathogenesis and/or identify deregulated metabolic pathway that can be potential candidates for treatment and being potential specific biomarkers of the disease. To gain more insight into those aspects in Chagas disease, we performed an unprecedented metabolomic analysis in heart and plasma of mice infected with T. cruzi. Many metabolic pathways were profoundly affected by T. cruzi infection, such as glucose uptake, sorbitol pathway, fatty acid and phospholipid synthesis that were increased in heart tissue but decreased in plasma. Tricarboxylic acid cycle was decreased in heart tissue and plasma whereas reactive oxygen species production and uric acid formation were also deeply increased in infected hearts suggesting a stressful condition in the heart. While specific metabolites allantoin, kynurenine and p-cresol sulfate, resulting from nucleotide, tryptophan and phenylalanine/tyrosine metabolism, respectively, were increased in heart tissue and also in plasma. These results provide new valuable information on the pathogenesis of acute Chagas disease, unravel several new metabolic pathways susceptible of clinical management and identify metabolites useful as potential specific biomarkers for monitoring treatment and clinical severity in patients.This work was supported by ‘‘Ministerio de Ciencia e Innovación’’ (SAF2010-17833); ‘‘Fondo de Investigaciones Sanitarias’’ (PS09/00538 and PI12/00289); ‘‘Red de Investigación de Centros de Enfermedades Tropicales’’ (RICET RD12/0018/0004); European Union (HEALTH-FE-2008-22303, ChagasEpiNet);‘‘Universidad Autónoma de Madrid’’ and ‘‘Comunidad de Madrid’’ (CC08-UAM/SAL-4440/08); AECID Cooperation with Argentine (A/025417/09 and A/031735/10), Comunidad de Madrid (S-2010/BMD-2332) and ‘‘Fundación Ramón Areces’Peer Reviewe

Fingolimod: therapeutic mechanisms and ocular adverse effects.

Fingolimod is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). We aim to review the published literature on ocular manifestations of fingolimod therapy and their possible underlying mechanisms. The therapeutic effects of fingolimod are mediated via sphingosine receptors, which are found ubiquitously in various organs, including lymphoid cells, central nervous system, cardiac myocytes, and smooth muscle cells. Fingolimod-associated macular oedema (FAME) is the most common ocular side effect but retinal haemorrhages and retinal vein occlusion can occur. The visual consequences appear to be mild and, in cases of FAME, resolution is often attained with discontinuation of therapy. However, in cases of retinal vein occlusion, discontinuation of fingolimod alone may not be sufficient and intra-vitreal therapy may be required. We also propose a pragmatic service pathway for monitoring patients on fingolimod therapy, which includes stratifying them by risk and visual acuity

Using a Non-Image-Based Medium-Throughput Assay for Screening Compounds Targeting N-myristoylation in Intracellular Leishmania Amastigotes

We have refined a medium-throughput assay to screen hit compounds for activity against N-myristoylation in intracellular amastigotes of Leishmania donovani. Using clinically-relevant stages of wild type parasites and an Alamar blue-based detection method, parasite survival following drug treatment of infected macrophages is monitored after macrophage lysis and transformation of freed amastigotes into replicative extracellular promastigotes. The latter transformation step is essential to amplify the signal for determination of parasite burden, a factor dependent on equivalent proliferation rate between samples. Validation of the assay has been achieved using the anti-leishmanial gold standard drugs, amphotericin B and miltefosine, with EC50 values correlating well with published values. This assay has been used, in parallel with enzyme activity data and direct assay on isolated extracellular amastigotes, to test lead-like and hit-like inhibitors of Leishmania Nmyristoyl transferase (NMT). These were derived both from validated in vivo inhibitors of Trypanosoma brucei NMT and a recent high-throughput screen against L. donovani NMT. Despite being a potent inhibitor of L. donovani NMT, the activity of the lead T. brucei NMT inhibitor (DDD85646) against L. donovani amastigotes is relatively poor. Encouragingly, analogues of DDD85646 show improved translation of enzyme to cellular activity. In testing the high-throughput L. donovani hits, we observed macrophage cytotoxicity with compounds from two of the four NMT-selective series identified, while all four series displayed low enzyme to cellular translation, also seen here with the T. brucei NMT inhibitors. Improvements in potency and physicochemical properties will be required to deliver attractive lead-like Leishmania NMT inhibitors

Psychological and functional impacts associated with restrictions in long-term care facilities (LTCF) due to the COVID-19 pandemic: A multicentre study

This is an Accepted Manuscript of an article published by Taylor & Francis in Aging and Mental Health on 2022-12-20, available at: https://doi.org/10.1080/13607863.2022.2158306Objectives: To analyze the impacts of the restrictions implemented in LTCF during the COVID-19 pandemic on the psychological and functional status of older adults. Design: A retrospective multicentre study. We hypothesize that the negative effects of the restrictions will lead to a higher rate of decline between the measures taken immediately before and after the lockdown than between the two measures taken before the lockdown. Setting and participants: 365 participants recruited in four Spanish LTCFs in Galicia and Valencia. Methods: Impacts of restrictions on cognitive (MMSE), affective (GDS) and functional status (Barthel index, Tinetti) were analyzed by Linear Mixed Models with random intercepts, random slopes, and personal and contextual factors as covariates. Results: Social measures covaried significantly with the cognitive and functional status but did not predict longitudinal change. MMSE, Barthel index and Tinetti scores decreased significantly across pre- and post-lockdown measurement times, but only the Tinetti scores showed a specific impact of the restrictions. Conclusions and Implications: Only performance-based functional measures showed the real impact of restrictions. The findings highlight the importance of having data from several pre-lockdown measurements to enable identification of changes that can be causally attributed to the restrictions. The findings also support the resilience of older adults in mitigating the effect of the restrictions.This work was financially supported with FEDER founds (‘A way to make Europe’) by the Spanish AEI (Doi: 10.13039/501100011033; Refs. PID2020-114521RB-C21 and PSI2017-89389-C2-1-R) and by the Galician Government (Consellería de Cultura, Educación e Ordenación Universitaria; axudas para a consolidación e estruturación de unidades de investigación competitivas do Sistema Universitario de Galicia ED431C 2021/04; GI-1807-USC: Ref. 2021-PG011).S

Does posterior capsule opacification affect the results of diagnostic technologies to evaluate the retina and the optic disc?

The visual outcome obtained after cataract removal may progressively decline because of posterior capsular opacification (PCO). This condition can be treated by creating an opening in the posterior lens capsule by Nd:YAG laser capsulotomy. PCO optical imperfections cause several light reflection, refraction, and diffraction phenomena, which may interfere with the functional and structural tests performed in different ocular locations for the diagnosis and follow-up of ocular disease, like macular and optic nerve diseases. Some parameters measured by visual field examinations, scanning laser polarimetry, and optical coherence tomography (OCT) have changed after PCO removal. Imaging quality also changes following capsulotomy. Consequently, the results of ancillary tests in pseudophakic eyes for studying ocular diseases like glaucoma or maculopathies should be correlated with other clinical examinations, for example, slit-lamp biomicroscopy or funduscopy. If PCO is clinically significant, a new baseline should be set for future comparisons following capsulotomy when using automated perimetry and scanning laser polarimetry. To perform OCT in the presence of PCO, reliable examinations (considering signal strength) apparently guarantee that measurements are not influenced by PCO

Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma

Glaucoma is the leading cause of irreversible blindness worldwide. Several risk factors have been involved in the pathogenesis of the disease. By now, the main treatable risk factor is elevated intraocular pressure. Nevertheless, some patients, whose intraocular pressure is considered in the target level, still experience a progression of the disease. Glaucoma is a form of multifactorial ocular neurodegeneration with complex etiology, pathogenesis, and pathology. New evidence strongly suggests brain involvement in all aspects of this disease. This hypothesis and the need to prevent glaucomatous progression led to a growing interest in the pharmacological research of new neuroprotective, non-IOP-lowering, agents. The aim of this paper is to report evidence of the usefulness of Coenzyme Q10 and Citicoline, eventually combined, in the prevention of glaucomatous neurodegeneration